Methods and compositions for the inhibition of modulation of T cell costimulatory pathway by a pathogenic agent

Details for Australian Patent Application No. 2004226566 (hide)

Owner Yissum Research Development Company of the Hebrew University of Jerusalem

Inventors Arad, Gila; Kaempfer, Raymond

Agent Davies Collison Cave

Pub. Number AU-B-2004226566

PCT Pub. Number WO2004/087196

Priority PCT/IL03/00278 03.04.03 IL

Filing date 1 April 2004

Wipo publication date 14 October 2004

Acceptance publication date 28 April 2011

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

17 November 2005 PCT application entered the National Phase

  PCT publication WO2004/087196 Priority application(s): WO2004/087196

28 April 2011 Application Accepted

  Published as AU-B-2004226566

25 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226578-Tissue-adhesive formulations

2004226561-Composite of support substrate and collagen, and process for producing support substrate and composite